Stakeholder point of view on prescription drug affordability - a systematic literature review and content analysis

Boris Rachev, Jennifer Uyei, Rajpal Singh, Stacey Kowal and C. Erwin Johnson

Health Policy, 2021, vol. 125, issue 9, 1158-1165

Abstract: The objectives of this research were to: 1) understand perspectives on affordability of pharmaceutical drugs from the point of view of stakeholders as reported in published peer-reviewed journals and conferences; 2) evaluate if (and how) perspectives on affordability overlapped across stakeholders.

Keywords: Prescription drug affordability; Affordability; Value metrics; Budget impact (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851021001706
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:125:y:2021:i:9:p:1158-1165

DOI: 10.1016/j.healthpol.2021.06.013

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().